Identification
- Composition (DCI)
- déférasirox
- Manufacturer
- NOVARTIS PHARMA MAROC
- ATC code
- V03AC03
- Presentation
- Boite de 28
- Schedule / Reimb.
- A
- Hospital price
- 2523.00 MAD
Indications
Traitement des hémosidéroses post-transfusionnelles. Traitement de la surcharge en fer chronique nécessitant un traitement chélateur chez les patients à partir de 10 ans présentant une thalassémie non dépendante des transfusions. Source : Compendium.ch - Date : 20 octobre 2025
Find an open pharmacy
On-call pharmacies near you
About EXJADE 500 MG
EXJADE 500 MG is marketed in Morocco by NOVARTIS PHARMA MAROC and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of EXJADE 500 MG, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about EXJADE 500 MG
Answers to common questions from Moroccan patients about this drug.